Literature DB >> 15224128

Tissue expression, distribution, and regulation of PDE5.

C-S Lin1.   

Abstract

Phosphodiesterase 5 (PDE5) has been identified in many species. The three isoforms, PDE5A1, PDE5A2, and PDE5A3, differ only in their N-terminal sequence. PDE5A1 and PDE5A2 are ubiquitous, but PDE5A3 is specific to smooth muscle. The initial three exons (A1-A3-A2) of PDE5A, located on chromosome 4q26, are alternative first exons encoding the isoform-specific sequences. The PDE5A promoter overlaps with the A1-specific exon, while the PDE5A2 promoter is located between the A3- and A2-specific exons. Both respond to cyclic guanosine monophosphate (cGMP) or cyclic adenosine monophosphate (cAMP) stimulation. The PDE5A2 promoter contains an Sp1-binding sequence critical for basal and cGMP/cAMP-inducible promoter activities. PDE5A is induced by adjacent sequences (enhancers) containing Sp1-binding sites. The potential role of PDE5A promoters in the tachyphylaxis effect of PDE5 inhibitors is currently being investigated. Preliminary data suggest that hypoxia might down-regulate PDE5A promoters, implying an involvement of PDE5 in stuttering priapism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224128     DOI: 10.1038/sj.ijir.3901207

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  25 in total

Review 1.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.

Authors:  Pui W Cheung; Richard Bouley; Dennis Brown
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

Review 3.  Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Authors:  Sevil Korkmaz-Icöz; Tamás Radovits; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

4.  Sildenafil as a Rescue Agent Following Intestinal Ischemia and Reperfusion Injury.

Authors:  Hannah M Moore; Natalie A Drucker; Brian D Hosfield; W Chris Shelley; Troy A Markel
Journal:  J Surg Res       Date:  2019-10-17       Impact factor: 2.192

5.  Differential expression of PDE5 in failing and nonfailing human myocardium.

Authors:  Xiaoyin Shan; Michael P Quaile; Jeffery K Monk; Benjamin French; Thomas P Cappola; Kenneth B Margulies
Journal:  Circ Heart Fail       Date:  2011-12-01       Impact factor: 8.790

6.  Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.

Authors:  Kabir H Biswas; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

7.  Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.

Authors:  Yousef Lahoud; Osamah Hussein; Amjad Shalabi; Omri Nativ; Hoda Awad; Mogher Khamaisi; Ibrahim Matar; Ofer Nativ; Zaid Abassi
Journal:  World J Urol       Date:  2015-05-16       Impact factor: 4.226

8.  Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease.

Authors:  Jole Fiorito; Faisal Saeed; Hong Zhang; Agnieszka Staniszewski; Yan Feng; Yitshak I Francis; Sudha Rao; Devarshi M Thakkar; Shi-Xian Deng; Donald W Landry; Ottavio Arancio
Journal:  Eur J Med Chem       Date:  2012-12-14       Impact factor: 6.514

9.  Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.

Authors:  Sakthivel Muniyan; Satyanarayana Rachagani; Seema Parte; Sushanta Halder; Parthasarathy Seshacharyulu; Prakash Kshirsagar; Jawed A Siddiqui; Raghupathy Vengoji; Sanchita Rauth; Ridwan Islam; Kavita Mallya; Kaustubh Datta; Lei Xi; Anindita Das; Benjamin A Teply; Rakesh C Kukreja; Surinder K Batra
Journal:  Clin Cancer Res       Date:  2020-08-26       Impact factor: 12.531

10.  Differential regulation of PDE5 expression in left and right ventricles of feline hypertrophy models.

Authors:  Xiaoyin Shan; Kenneth B Margulies
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.